369 related articles for article (PubMed ID: 24029171)
1. Transungual delivery of ketoconazole using novel lacquer formulation.
Hafeez F; Hui X; Chiang A; Hornby S; Maibach H
Int J Pharm; 2013 Nov; 456(2):357-61. PubMed ID: 24029171
[TBL] [Abstract][Full Text] [Related]
2. Ciclopirox delivery into the human nail plate using novel lipid diffusion enhancers.
Hafeez F; Hui X; Selner M; Rosenthal B; Maibach H
Drug Dev Ind Pharm; 2014 Jun; 40(6):838-44. PubMed ID: 23600655
[TBL] [Abstract][Full Text] [Related]
3. Efinaconazole topical solution, 10%: formulation development program of a new topical treatment of toenail onychomycosis.
Bhatt V; Pillai R
J Pharm Sci; 2015 Jul; 104(7):2177-82. PubMed ID: 25940933
[TBL] [Abstract][Full Text] [Related]
4. Hydrosoluble medicated nail lacquers: in vitro drug permeation and corresponding antimycotic activity.
Monti D; Saccomani L; Chetoni P; Burgalassi S; Senesi S; Ghelardi E; Mailland F
Br J Dermatol; 2010 Feb; 162(2):311-7. PubMed ID: 19886884
[TBL] [Abstract][Full Text] [Related]
5. Enhancing transungual delivery and spreading of efinaconazole under the nail plate through a unique formulation approach.
Kircik LH
J Drugs Dermatol; 2014 Dec; 13(12):1457-61. PubMed ID: 25607788
[TBL] [Abstract][Full Text] [Related]
6. Development of ciclopirox nail lacquer with enhanced permeation and retention.
Thapa RK; Choi JY; Go TG; Kang MH; Han SD; Jun JH; Son MW; Yong CS; Kim JO
Arch Pharm Res; 2016 Jul; 39(7):953-9. PubMed ID: 27306785
[TBL] [Abstract][Full Text] [Related]
7. Transungual delivery of efinaconazole: its deposition in the nail of onychomycosis patients and in vitro fungicidal activity in human nails.
Sakamoto M; Sugimoto N; Kawabata H; Yamakawa E; Kodera N; Pillai R; Tatsumi Y
J Drugs Dermatol; 2014 Nov; 13(11):1388-92. PubMed ID: 25607707
[TBL] [Abstract][Full Text] [Related]
8. Development of topical therapeutics for management of onychomycosis and other nail disorders: a pharmaceutical perspective.
Elsayed MM
J Control Release; 2015 Feb; 199():132-44. PubMed ID: 25481439
[TBL] [Abstract][Full Text] [Related]
9. High failure rate of transungal drug delivery: need for new strategies.
Tiwary AK; Sapra B
Ther Deliv; 2017 Mar; 8(5):239-242. PubMed ID: 28361611
[No Abstract] [Full Text] [Related]
10. Potential of Naftifine Application for Transungual Delivery.
Šveikauskaitė I; Briedis V
Molecules; 2020 Jul; 25(13):. PubMed ID: 32635240
[TBL] [Abstract][Full Text] [Related]
11. Influence of human nail etching for the assessment of topical onychomycosis therapies.
Repka MA; Mididoddi PK; Stodghill SP
Int J Pharm; 2004 Sep; 282(1-2):95-106. PubMed ID: 15336385
[TBL] [Abstract][Full Text] [Related]
12. Optimized Ciclopirox-Based Eudragit RLPO Nail Lacquer: Effect of Endopeptidase Enzyme as Permeation Enhancer on Transungual Drug Delivery and Efficiency Against Onychomycosis.
Khattab A; Shalaby S
AAPS PharmSciTech; 2018 Apr; 19(3):1048-1060. PubMed ID: 29138987
[TBL] [Abstract][Full Text] [Related]
13. The dermatopharmacologic profile of ciclopirox 8% nail lacquer.
Bohn M; Kraemer K
J Am Podiatr Med Assoc; 2000; 90(10):491-4. PubMed ID: 11107709
[TBL] [Abstract][Full Text] [Related]
14. Dermatopharmacology of ciclopirox nail lacquer topical solution 8% in the treatment of onychomycosis.
Bohn M; Kraemer KT
J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S57-69. PubMed ID: 11051135
[TBL] [Abstract][Full Text] [Related]
15. Formulation evaluation of ketoconazole microemulsion-loaded hydrogel with nigella oil as a penetration enhancer.
Amra K; Momin M
J Cosmet Dermatol; 2019 Dec; 18(6):1742-1750. PubMed ID: 30980617
[TBL] [Abstract][Full Text] [Related]
16. Validation of bovine hoof slices as a model for infected human toenails: in vitro ciclopirox transungual permeation.
Monti D; Saccomani L; Chetoni P; Burgalassi S; Tampucci S; Mailland F
Br J Dermatol; 2011 Jul; 165(1):99-105. PubMed ID: 21410668
[TBL] [Abstract][Full Text] [Related]
17. Preparation and
Lee BC; Pangeni R; Na J; Koo KT; Park JW
Drug Deliv; 2019 Dec; 26(1):1167-1177. PubMed ID: 31738083
[TBL] [Abstract][Full Text] [Related]
18. Enhanced Ungual Permeation of Terbinafine HCl Delivered Through Liposome-Loaded Nail Lacquer Formulation Optimized by QbD Approach.
Shah VH; Jobanputra A
AAPS PharmSciTech; 2018 Jan; 19(1):213-224. PubMed ID: 28681334
[TBL] [Abstract][Full Text] [Related]
19. Ungual and transungual drug delivery.
Shivakumar HN; Juluri A; Desai BG; Murthy SN
Drug Dev Ind Pharm; 2012 Aug; 38(8):901-11. PubMed ID: 22149347
[TBL] [Abstract][Full Text] [Related]
20. Permeation studies of novel terbinafine formulations containing hydrophobins through human nails in vitro.
Vejnovic I; Huonder C; Betz G
Int J Pharm; 2010 Sep; 397(1-2):67-76. PubMed ID: 20620203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
